| Smiles |
O=C1(N6(C(C(=O)NC(C(O)C(=O)NC(C(=O)NCC(=O)N4(C(C(=O)N3(CC(C(C3(C(NC(C(NC(C(NC(C(NCC(NC1C(O)C(C)C)=O)=O)CC2(=CC=CC=C2))=O)CCO)=O)CC(C)C)=O))C)O))C(C)C(C4)O))CO)CC(OC(=O)C(NC(=O)C)C)CCCC(O)CC5(=CC=CC=C5))C(C)CC6))
|
| CAS number |
112793-66-5
|
| Polar Surface Area |
490,74
|
| calculated LogS |
-4,898
|
| Molweight |
1463,69
|
| calculated LogP |
-3,1319
|
| H-Acceptors |
33
|
| H-Donors |
16
|
| Ro5 violations |
3
|
| Druglikeness |
0,095338
|
| DrugScore |
0,2905286
|
| Mutagenic |
none
|
| Tumorigenic |
none
|
| Reproductive Effective |
none
|
| Irritant |
none
|
| Fish Toxicity |
High FHMT
|
| Fish Toxicity2 |
1,4983
|
| Rat Acute Toxicity |
2,9005
|
| Acute Oral Toxicity |
III
|
| Caco-2 Permeability |
Caco2-
|
| Caco-2 Permeability2 |
-0,0187
|
| P-glycoprotein Substrate |
Substrate
|
| P-glycoprotein Inhibitor |
Inhibitor
|
| P-glycoprotein Inhibitor2 |
Inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition |
Weak inhibitor
|
| Human Ether-a-go-go-Related Gene Inhibition2 |
Inhibitor
|
| CYP450 2C9 Substrate |
Non-substrate
|
| Tetrahymena Pyriformis Toxicity |
High TPT
|
| Tetrahymena Pyriformis Toxicity2 |
0,5275
|
| AMES Toxicity |
Non AMES toxic
|
| CYP450 3A4 Substrate |
Substrate
|
| CYP450 3A4 Inhibitor |
Non-inhibitor
|
| CYP450 2C19 Inhibitor |
Non-inhibitor
|
| CYP450 2C9 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Inhibitor |
Non-inhibitor
|
| CYP450 1A2 Inhibitor |
Non-inhibitor
|
| CYP450 2D6 Substrate |
Non-substrate
|
| Biodegradation |
Not ready biodegradable
|
| Carcinogens |
Non-carcinogens
|
| Blood-Brain Barrier |
BBB-
|
| CYP Inhibitory Promiscuity |
Low CYP Inhibitory Promiscuity
|
| Honey Bee Toxicity |
Low HBT
|
| Renal Organic Cation Transporter |
Non-inhibitor
|
| Carcinogenicity (Three-class) |
Non-required
|
| Human Intestinal Absorption |
HIA-
|
| Structure |
112793-66-5
|
